Evidence map›Paper›PMID 9573265›Full record

ArticleJournal of virology1998

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.

D L Tuttle, J K Harrison, C Anders, J W Sleasman, M M Goodenow

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 2 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. HIV Latency in Myeloid Cells: Challenges for a Cure.Pathogens (Basel, Switzerland) · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Protein Palmitoylation in Leukocyte Signaling and Function.Frontiers in cell and developmental biology · 2020
    Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

D L TuttleDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida 32610, USA.
J K Harrison
C Anders
J W Sleasman
M M Goodenow
Florida College · USUniversity of Florida · US

Funding

Human Immunodeficiency Virus ProteinaseR37AI028571 · NIAID · UNIVERSITY OF FLORIDA · PI DUNN, BEN M. · 2005 to 2014
$3.8M
TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCERT32CA009126 · NCI · UNIVERSITY OF FLORIDA · PI MAY, WILLIAM STRATFORD · 1985 to 2012
$3.5M
HIV-1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR01HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1995 to 2007
$2.8M
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASER01AI028571 · NIAID · UNIVERSITY OF FLORIDA · PI DUNN, BEN M. · 1989 to 2004
$1.3M
ACTIVATION OF HIV-1 IN MACROPHAGES BY LUNG CELLSR01HL058005 · NHLBI · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1996 to 2000
$290k
HIV 1 VARIANTS WITHIN PBMC SUBPOPULATIONS IN INFANTSR55HD032259 · NICHD · UNIVERSITY OF FLORIDA · PI GOODENOW, MAUREEN M · 1994 to 1994
–
NCI NIH HHS T32 CA009126NHLBI NIH HHS HL58005NIAID NIH HHS AI28571NIAID NIH HHS R01 AI028571NIAID NIH HHS R37 AI028571NICHD NIH HHS HD32259NICHD NIH HHS R01 HD032259
6 · The paper itself

Abstract

The stage of differentiation and the lineage of CD4+ cells profoundly affect their susceptibility to infection by human immunodeficiency virus type 1 (HIV-1). While CD4(+) T lymphocytes in patients are readily susceptible to HIV-1 infection, peripheral blood monocytes are relatively resistant during acute or early infection, even though monocytes also express CD4 and viral strains with macrophage (M)-tropic phenotypes predominate. CCR5, the main coreceptor for M-tropic viruses, clearly contributes to the ability of CD4+ T cells to be infected. To determine whether low levels of CCR5 expression account for the block in infection of monocytes, we examined primary monocyte lineage cells during differentiation. Culturing of blood monocytes for 5 days led to an increase in the mean number of CCR5-positive cells from <20% of monocytes to >80% of monocyte-derived macrophages (MDM). Levels of CCR5 expression per monocyte were generally lower than those on MDM, perhaps below a minimum threshold level necessary for efficient infection. Productive infection may be restricted to the small subset of monocytes that express relatively high levels of CCR5. Steady-state CCR5 mRNA levels also increased four- to fivefold during MDM differentiation. Infection of MDM by M-tropic HIV-1JRFL resulted in >10-fold-higher levels of p24, and MDM harbored >30-fold more HIV-1 DNA copies than monocytes. In the presence of the CCR5-specific monoclonal antibody (MAb) 2D7, virus production and cellular levels of HIV-1 DNA were decreased by >80% in MDM, indicating a block in viral entry. There was a direct association between levels of CCR5 and differentiation of monocytes to macrophages. Levels of CCR5 were related to monocyte resistance and macrophage susceptibility to infection because infection by the M-tropic strain HIV-1JRFL could be blocked by MAb 2D7. These results provide direct evidence that CCR5 functions as a coreceptor for HIV-1 infection of primary macrophages.

Indexed as

HIV-1Cell DifferentiationCells, CulturedDisease SusceptibilityHIV InfectionsHumansMacrophagesMonocytesReceptors, CCR5Receptors, VirusReceptors, CCR5Receptors, Virus

Identifiers

PMID9573265
PMCPMC110058
OpenAlexW2165627434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.